CDMO News and Press, Avid Bioservices Inc. From 03/07/24

NEW YORK, NY / ACCESSWIRE / March 7, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Avid Bioservices, Inc. ("Avid Bioservices" or "the Company") (NASDAQ:CDMO). Investors who purchased Avid Bioservices securities are encouraged to obtain...

2024-03-07 12:49:07 ET More on Mid-day movers & stocks. Financial information for Nature Wood Group Financial information for Psyence Biomedical Ltd. Read the full article on Seeking Alpha For further details see: PBM and NWGL among mid-day movers

2024-03-07 10:01:04 ET More on Health Care Select Sector SPDR XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming Waters, Moderna most shorted ...

2024-03-07 08:35:57 ET More on Pre-market losers & stocks. Rail Vision shares rally as Main Line System gets EU approval and certifications Rail Vision wins contract valued at up to $5 million, shares jump Financial information for Airship AI Holdings, Inc. ...

2024-03-07 08:05:19 ET More on Avid Bioservices Laughing Water Capital - Avid Bioservices: Substantial Future Earnings Power, Strong Competitive Position Avid Bioservices: Don't Miss The Bigger Picture Avid Bioservices says revenues for third quarter of fiscal 2024 w...

TUSTIN, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO), announced today the pricing of $160 million aggregate principal amount of 7.00% Convertible Senior Notes due 2029 (the “...

2024-03-06 16:41:51 ET More on Avid Bioservices Laughing Water Capital - Avid Bioservices: Substantial Future Earnings Power, Strong Competitive Position Avid Bioservices: Don't Miss The Bigger Picture Avid Bioservices, Inc. (CDMO) Q2 2024 Earnings Call Transcript ...

TUSTIN, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO), announced today that it intends to offer, subject to market conditions and other factors, $160 million aggregate principal amo...

TUSTIN, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pha...

2024-02-14 14:11:46 ET More on Charles River, IQVIA, etc. Charles River Laboratories International, Inc. (CRL) Q4 2023 Earnings Call Transcript Medpace Holdings, Inc. (MEDP) Q4 2023 Earnings Call Transcript Medpace Holdings, Inc. 2023 Q4 - Results - Earnings Call Pre...